Latest Advisory

Change of Venue for QPIRA CDRR-VX on 18-19 September 2018

Please be informed that the conduct of QPIRA for Center for Drug Regulation and Research on Vaccine Seminar on 18-19 September has been change to Vivere Hotel

  • Seminar Venue: FROM the Bellevue Manila TO Vivere Hotel
  • Address: Alabang Muntinlupa City Metro Manila

For inquiries and other concerns, please call the FDA Academy at the FDA Academy at the telephone number (02) 877 0259 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Attachments:
Download this file (QCDRR-VX.pdf)QCDRR-VX.pdf

Reschedule of the Unified Licensing Seminar for NCR and Region IV-A Stakeholders (ULS-NCR)

Please be informed that the conduct of the Reschedule of the Unified Licensing Seminar for NCR and Region IV-A Stakeholders (Course Code: ULS-NCR) sset on 14 September 2018 shall be rescheduled tp 25 September 2018 due to possible threat of typhome Ompong (Mangkhut).

Please visit the FDA website and Facebook page for more update on this seminar. For inquiries and other concerns, please call the FDA Academy at telephone number (02) 877 0259 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Seminar Venue for QPIRA CDRRHR on 20-21 September 2018

Please be informed that the conduct of QPIRA for Center for Device Regulation and Research Seminar on 20-21 September 2018 shall be held at The Bellevue Manila.

Seminar : The Bellevue Manila
Address : North Bridgeway, Filinvest Corporate City, Alabang, Muntinlupa City, Metro Manila

For Inquiries and other concerns, please call the FDA Academy at telephone number (02) 877 0259 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Seminar Venue for QPIRA CDRR - VACCINE on 18-19 September 2018

Please be informed that the conduct of QPIRA for Center for Drug Regulation and Research Seminar on 18-19 September 2018 shall be held at The Bellevue Manila.

Seminar : The Bellevue Manila
Address : North Bridgeway, Filinvest Corporate City, Alabang, Muntinlupa City, Metro Manila

For Inquiries and other concerns, please call the FDA Academy at telephone number (02) 877 0259 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Impact of Cash-Based Budgeting (CBB) on Health Research Projects

We Would like to inform your good office of the outcome of the meeting with the Department of Budget and Management last August 3, 2108. After the consultation, the following were clarified:

  1. The 2018 research budget is still under Obligation Based Budgeting (OBB). This implies that the 2018 MOA with PCHRD on AHEAF-HPSR will follwo mechanism applied in previous years wherein the funds are held in trust, and as such will expire only upon project completion.
  2. The 2019 research budget is under Cash Based Budgeting (CBB). Thus, all agreed outputs, as per contract, need to be delivered by December 2019 and payments can be made until March 20120, the end of the extended payment period of 3-months. Outputs submitted by December 0219 shall not be paid. Hence, DBM strongly advised all offices with research engagements, to complete all "pre-implementation" activities - as in the case of PCHRD (or all pre-procurement activities, if through COBAC), such as Call for Proposals, Technical and Ethical Review & MOA signing by December 2018, such that January 2019 should be already be the start if the implementation of the research project.
  3. Since the same timeline shall hold true for sub-allotted funds, all offices planning to suballot research funds shall coordinate with implementing units as early as now.

Should you have any concerns, please contact Mr. Pio Justing Asunscion (Senior Health Program Officer) or Ms. Gilmeri Peach Mallorca (AHEAD Program Manager) at (02) 951-7800 local 1326/1328.

Thank you very much for your continued support.

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter